Work

Anxiety and depression in patients with moderate‐to‐severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study

Year: 2018

Type: article

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.15012

Authors: K.B. Gordon, A.W. Armstrong, C. Han, P. Foley, M. Song, Y. Wasfi, Y. You, Y.‐K. Shen, K. Reich

Institutions: Medical College of Wisconsin, University of Southern California, The University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development

OpenAlex ID: W2799670772

FWCI: 3.577

Cites: 42

Cited by: 97

Related to: 10